Taltz 80 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FE9KB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,506
Award facts
- Contract value 100% obligated
- $18,505.82 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $18,505.82 delivery order to AmerSourceBergen Drug Corp for TALTZ 80 mg/ml autoinjector on January 26, 2026, with an ultimate completion date of January 27, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at AmerSourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child delivery order issued under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999.99 million and extending through December 2031, which serves as the primary vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally.
TALTZ (ixekizumab) is a biologic immunosuppressant medication used to treat inflammatory conditions including psoriasis and rheumatoid arthritis. This delivery order represents a routine pharmaceutical procurement through DLA's established medical supply chain, leveraging AmerSourceBergen's extensive portfolio of brand-name and generic medications across multiple therapeutic domains. As a major pharmaceutical distributor, AmerSourceBergen serves critical federal medical procurement needs for the Department of Defense, Defense Health Agency, and other government healthcare systems through its comprehensive supply capabilities and established distribution infrastructure.
Quick answers
Who was awarded contract SPE2DR26FE9KB?
SPE2DR26FE9KB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 26, 2026.
How much is contract SPE2DR26FE9KB worth?
The government has obligated $18,506 on SPE2DR26FE9KB.
Is contract SPE2DR26FE9KB an order under another contract?
Yes. SPE2DR26FE9KB is a delivery order under SPE2DR25D3104, an indefinite delivery contract.
Was contract SPE2DR26FE9KB competed?
The extent of competition for SPE2DR26FE9KB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award